STOCK TITAN

Anika (NASDAQ: ANIK) CEO exercises RSUs, withholds shares to cover tax

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Anika Therapeutics President and CEO Stephen D. Griffin exercised restricted stock units and had shares withheld for taxes. On June 3, 2026, 12,840 RSUs converted into the same number of common shares, and 3,769 shares were retained by the company to satisfy tax withholding obligations. Following these transactions, he directly holds 49,742 shares of Anika common stock. The vesting represents the second of three equal annual installments from a 38,520 RSU grant originally awarded on June 3, 2024.

Positive

  • None.

Negative

  • None.
Insider Griffin Stephen D.
Role President and CEO
Type Security Shares Price Value
Exercise Restricted Stock Unit 12,840 $0.00 --
Exercise Common Stock 12,840 $0.00 --
Tax Withholding Common Stock 3,769 $14.41 $54K
Holdings After Transaction: Restricted Stock Unit — 12,840 shares (Direct, null); Common Stock — 49,742 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan. Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026. On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award.
RSUs converted 12,840 units RSUs converted into common stock on June 3, 2026
Shares withheld for tax 3,769 shares Retained by Anika to satisfy tax withholding on June 3, 2026
Post-transaction holdings 49,742 shares Common shares directly held by CEO after transactions
Original RSU grant 38,520 RSUs Grant dated June 3, 2024 vesting in three equal annual installments
ESPP acquisition 739 shares Shares acquired on May 14, 2026 under Employee Stock Purchase Plan
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026."
Employee Stock Purchase Plan financial
"Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Griffin Stephen D.

(Last)(First)(Middle)
C/O ANIKA THERAPEUTICS, INC.
32 WIGGINS AVENUE

(Street)
BEDFORD MASSACHUSETTS 01730

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Anika Therapeutics, Inc. [ ANIK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026M12,840A(1)49,742(2)D
Common Stock06/03/2026F3,769(3)D$14.4145,973D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/03/2026M12,840 (4) (4)Common Stock12,840$012,840D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
2. Includes 739 shares acquired on May 14, 2026 under the Anika Therapeutics, Inc. Employee Stock Purchase Plan.
3. Reflects an aggregate of 3,769 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on June 3, 2026.
4. On June 3, 2024, the Reporting Person was granted 38,520 RSUs vesting in three equal annual installments beginning on June 3, 2025. This transaction reflects the second vesting installment of such RSU award.
/s/ Stephen D. Griffin06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Anika (ANIK) CEO Stephen Griffin report?

Stephen Griffin reported RSU vesting and tax withholding transactions. On June 3, 2026, 12,840 restricted stock units converted into common shares, and 3,769 of those shares were withheld by Anika to cover tax obligations tied to the vesting event.

Did the Anika (ANIK) CEO sell shares on the open market in this Form 4?

The Form 4 shows no open-market share sales. Shares were withheld by Anika to cover tax obligations related to RSU vesting, which is a non-market transaction and differs from discretionary buying or selling in the open market.

How many Anika (ANIK) shares were withheld for taxes in this filing?

Anika retained 3,769 common shares to satisfy tax withholding. These shares relate to restricted stock units that vested on June 3, 2026, and the withholding is described as covering tax obligations rather than representing a market sale by the CEO.

How many restricted stock units vested for the Anika (ANIK) CEO?

12,840 restricted stock units vested and converted into common shares. The filing notes this as the second of three equal annual installments from a 38,520 RSU grant originally awarded on June 3, 2024 to Stephen D. Griffin.

What are the Anika (ANIK) CEO’s direct share holdings after these transactions?

Stephen Griffin holds 49,742 Anika common shares directly after the transactions. This total reflects the net impact of the 12,840 RSU conversion into shares and the 3,769 shares withheld by the company to satisfy tax withholding obligations.

What does each RSU represent in the Anika (ANIK) CEO’s Form 4?

Each restricted stock unit represents the right to receive one share of common stock. The filing states that every RSU converts on a one-for-one basis into Anika common shares when vesting conditions are met, as occurred on June 3, 2026.